Journey Medical DERM Cash Flow Statement (2020-2026)

NASDAQ DERM
$7.49 +0.68 (+9.99%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-10.65M-21.75M-1.38M-7.53M-10.08M-10.64M-10.14M-8.36M16.79M-2.14M-10.44M-3.36M-2.39M1.58M-4.07M-3.80M-2.31M-1.23M-2.23M-0.31M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
0.01M1.40M0.77M0.77M1.44M1.44M0.65M0.87M0.56M0.53M1.41M1.67M1.64M1.38M1.32M2.50M1.85M1.77M0.99M1.44M
Deferred Taxes (Quarter)
-3.29M8.27M
Asset Writedowns and Impairment (Quarter)
-0.01M0.12M-0.08M0.03M0.06M0.27M0.13M3.14M-0.13M-0.04M0.01M0.15M0.67M-0.31M0.20M-0.44M0.08M-0.04M0.03M-0.01M
Cash from Operations (Quarter)
7.10M-3.21M0.88M-3.30M-7.28M-3.84M-0.96M3.97M18.75M-16.52M-5.02M-5.18M-1.16M2.23M-2.83M-0.94M-2.38M-6.28M2.91M-1.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.38M1.92M0.01M0.02M0.02M0.02M0.02M0.28M0.06M0.00M0.06M0.06M0.09M0.09M0.10M0.12M0.12M0.12M0.10M0.10M
Amortization of Deferred Charges (Quarter)
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Depreciation & Amortization (CF) (Quarter)
Change in Working Capital
Change in Receivables (Quarter)
5.54M-8.51M8.00M-2.48M-0.08M-0.05M-0.47M-10.43M-8.83M7.18M-5.42M0.81M0.88M-0.75M7.99M-2.82M2.42M11.76M-4.76M11.24M
Change in Inventory (Quarter)
-2.70M-1.75M0.23M-0.08M-0.82M-1.07M-0.88M-1.11M-1.14M-0.82M0.37M-0.89M2.10M2.64M-1.94M0.36M-1.03M-2.19M-0.33M-1.14M
Change in Account Payables (Quarter)
9.50M-5.46M4.73M5.79M0.88M2.94M7.09M-11.88M-3.61M-10.02M-2.81M-0.74M0.73M0.71M-1.65M-1.65M-1.20M-2.71M-0.65M-0.15M
Change in Accured Expenses (Quarter)
-10.52M-2.12M0.07M-3.65M-1.58M1.60M0.01M-0.08M-0.08M0.02M0.22M-4.60M0.04M1.42M5.59M-5.57M3.76M-3.78M-0.01M5.73M
Change in Taxes (Quarter)
0.01M0.10M-0.10M0.01M0.01M-0.08M-0.02M-0.04M0.06M-0.00M0.01M-0.00M
Other Working Capital Changes (Quarter)
1.69M0.03M-0.03M-0.01M-0.01M-0.01M-0.83M-0.68M-0.87M2.66M-1.01M-0.17M-1.16M2.34M-0.82M0.08M-0.84M1.74M0.09M-0.73M
Investing Activities
Capital Expenditures (Quarter)
20.00M5.00M
Cash from Investing Activities (Quarter)
-1.20M-20.00M-5.00M
Financing Activities
Other financing activities (Quarter)
31.27M3.40M21.34M0.10M0.07M0.02M0.08M0.04M0.10M0.24M-0.13M0.15M0.08M
Cash from Financing Activities (Quarter)
11.21M31.80M11.37M0.11M4.03M0.95M0.05M-13.09M-10.98M19.21M1.64M5.03M-0.29M10.62M3.60M0.17M7.04M5.43M0.22M0.16M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
4.63M1.48M0.19M6.20M4.05M6.89M5.42M
Additional items
Change in Cash (Quarter)
9.51M27.39M-7.75M-3.19M-3.25M-2.89M-5.90M-9.12M7.77M2.69M-3.38M-0.14M-1.45M-2.16M0.77M-0.78M4.66M-0.86M3.13M-1.58M
Free Cash Flow (Quarter)
7.10M-3.21M-19.12M-3.30M-7.28M-3.84M-5.96M3.97M18.75M-16.52M-5.02M-5.18M-1.16M2.23M-2.83M-0.94M-2.38M-6.28M2.91M-1.73M
Net Cash Flow (Quarter)
18.31M27.39M-7.75M-3.19M-3.25M-2.89M-5.90M-9.12M7.77M2.69M-3.38M-0.14M-1.45M12.84M0.77M-0.78M4.66M-0.86M3.13M-1.58M